• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺炎导致的急性呼吸窘迫综合征致死病例的临床表型。

Clinical phenotypes from fatal cases of acute respiratory distress syndrome caused by pneumonia.

机构信息

Division of Respiratory Medicine, Saiseikai Kumamoto Hospital, 5-3-1 Chikami, Kumamoto, 861-4101, Japan.

Department of Radiology, Kansai Rosai Hospital, Amagasaki, Hyogo, 660-8511, Japan.

出版信息

Sci Rep. 2021 Oct 8;11(1):20051. doi: 10.1038/s41598-021-99540-1.

DOI:10.1038/s41598-021-99540-1
PMID:34625618
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8501115/
Abstract

There have been no report of objective clinical characteristics or prognostic factors that predict fatal outcome of acute respiratory distress syndrome (ARDS) since the Berlin definition was published. The aim of this study is to identify clinically available predictors that distinguish between two phenotypes of fatal ARDS due to pneumonia. In total, 104 cases of Japanese patients with pneumonia-induced ARDS were extracted from our prospectively collected database. Fatal cases were divided into early (< 7 days after diagnosis) and late (≥ 7 days) death groups, and clinical variables and prognostic factors were statistically evaluated. Of the 50 patients who died within 180 days, 18 (36%) and 32 (64%) were in the early (median 2 days, IQR [1, 5]) and late (median 16 days, IQR [13, 29]) death groups, respectively. According to multivariate regression analyses, the APACHE II score (HR 1.25, 95%CI 1.12-1.39, p < 0.001) and the disseminated intravascular coagulation score (HR 1.54, 95%CI 1.15-2.04, p = 0.003) were independent prognostic factors for early death. In contrast, late death was associated with high-resolution computed tomography (HRCT) score indicating early fibroproliferation (HR 1.28, 95%CI 1.13-1.42, p < 0.001) as well as the disseminated intravascular coagulation score (HR 1.24, 95%CI 1.01-1.52, p = 0.039). The extent of fibroproliferation on HRCT, and the APACHE II scores along with coagulation abnormalities, should be considered for use in predictive enrichment and personalized medicine for patients with ARDS due to pneumonia.

摘要

自柏林定义发布以来,尚无关于预测急性呼吸窘迫综合征(ARDS)致命结局的客观临床特征或预后因素的报道。本研究旨在确定可用于区分两种肺炎引起的致命性 ARDS 表型的临床可用预测因子。总共从我们前瞻性收集的数据库中提取了 104 例日本肺炎相关性 ARDS 患者。将致命病例分为早期(诊断后<7 天)和晚期(≥7 天)死亡组,并对临床变量和预后因素进行统计学评估。在 180 天内死亡的 50 例患者中,18 例(36%)和 32 例(64%)分别属于早期(中位数 2 天,IQR[1,5])和晚期(中位数 16 天,IQR[13,29])死亡组。根据多变量回归分析,APACHE II 评分(HR1.25,95%CI1.12-1.39,p<0.001)和弥散性血管内凝血评分(HR1.54,95%CI1.15-2.04,p=0.003)是早期死亡的独立预后因素。相反,晚期死亡与早期纤维化的高分辨率计算机断层扫描(HRCT)评分(HR1.28,95%CI1.13-1.42,p<0.001)以及弥散性血管内凝血评分(HR1.24,95%CI1.01-1.52,p=0.039)相关。HRCT 上纤维化的程度以及 APACHE II 评分和凝血异常,应考虑用于预测性富集和肺炎相关性 ARDS 患者的个体化治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7368/8501115/0f9dc58f424a/41598_2021_99540_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7368/8501115/3d0486669bc2/41598_2021_99540_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7368/8501115/b6461397fc48/41598_2021_99540_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7368/8501115/0f9dc58f424a/41598_2021_99540_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7368/8501115/3d0486669bc2/41598_2021_99540_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7368/8501115/b6461397fc48/41598_2021_99540_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7368/8501115/0f9dc58f424a/41598_2021_99540_Fig3_HTML.jpg

相似文献

1
Clinical phenotypes from fatal cases of acute respiratory distress syndrome caused by pneumonia.肺炎导致的急性呼吸窘迫综合征致死病例的临床表型。
Sci Rep. 2021 Oct 8;11(1):20051. doi: 10.1038/s41598-021-99540-1.
2
Prognostic values of the Berlin definition criteria, blood lactate level, and fibroproliferative changes on high-resolution computed tomography in ARDS patients.柏林定义标准、血乳酸水平和 ARDS 患者高分辨率 CT 上纤维增生性改变的预后价值。
BMC Pulm Med. 2019 Feb 11;19(1):37. doi: 10.1186/s12890-019-0803-0.
3
A Scoring System with High-Resolution Computed Tomography to Predict Drug-Associated Acute Respiratory Distress Syndrome: Development and Internal Validation.基于高分辨率计算机断层扫描的药物相关性急性呼吸窘迫综合征预测评分系统:开发与内部验证。
Sci Rep. 2019 Jun 13;9(1):8601. doi: 10.1038/s41598-019-45063-9.
4
[Value of procalcitonin on predicting the severity and prognosis in patients with early ARDS: a prospective observation study].[降钙素原对早期急性呼吸窘迫综合征患者严重程度及预后的预测价值:一项前瞻性观察研究]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2017 Jan;29(1):34-38. doi: 10.3760/cma.j.issn.2095-4352.2017.01.008.
5
[Value of radiographic assessment of lung edema score in evaluating the severity and prognosis of patients with acute respiratory distress syndrome].[肺水肿评分的影像学评估在急性呼吸窘迫综合征患者病情严重程度及预后评估中的价值]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021 May;33(5):557-562. doi: 10.3760/cma.j.cn121430-20201231-00780.
6
Analysis of clinical characteristics and prognostic factors of ARDS caused by community-acquired pneumonia in people with different immune status.分析不同免疫状态人群社区获得性肺炎所致急性呼吸窘迫综合征的临床特征及预后因素。
Expert Rev Anti Infect Ther. 2022 Dec;20(12):1643-1650. doi: 10.1080/14787210.2022.2142116. Epub 2022 Nov 3.
7
Prognostic factors for ARDS: clinical, physiological and atypical immunodeficiency.急性呼吸窘迫综合征的预后因素:临床、生理和非典型免疫缺陷。
BMC Pulm Med. 2020 Apr 23;20(1):102. doi: 10.1186/s12890-020-1131-0.
8
Detection of fibroproliferation by chest high-resolution CT scan in resolving ARDS.在急性呼吸窘迫综合征(ARDS)缓解期通过胸部高分辨率CT扫描检测纤维增生
Chest. 2014 Nov;146(5):1196-1204. doi: 10.1378/chest.13-2708.
9
Clinical characteristics and prognosis of drug-associated acute respiratory distress syndrome compared with non-drug-associated acute respiratory distress syndrome: a single-centre retrospective study in Japan.与非药物相关性急性呼吸窘迫综合征相比,药物相关性急性呼吸窘迫综合征的临床特征和预后:日本单中心回顾性研究。
BMJ Open. 2017 Nov 8;7(11):e015330. doi: 10.1136/bmjopen-2016-015330.
10
Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China.中国武汉 2019 年冠状病毒病肺炎患者急性呼吸窘迫综合征和死亡的相关危险因素。
JAMA Intern Med. 2020 Jul 1;180(7):934-943. doi: 10.1001/jamainternmed.2020.0994.

引用本文的文献

1
Clinical efficacy of invimestrocel for acute respiratory distress syndrome caused by pneumonia: Comparison with historical data using propensity score analysis.因维美司特治疗肺炎所致急性呼吸窘迫综合征的临床疗效:使用倾向评分分析与历史数据比较。
Regen Ther. 2025 Mar 8;29:35-42. doi: 10.1016/j.reth.2025.02.018. eCollection 2025 Jun.
2
Clinical efficacy and safety of multipotent adult progenitor cells (invimestrocel) for acute respiratory distress syndrome (ARDS) caused by pneumonia: a randomized, open-label, standard therapy-controlled, phase 2 multicenter study (ONE-BRIDGE).多能成年祖细胞(invimestrocel)治疗肺炎引起的急性呼吸窘迫综合征(ARDS)的临床疗效和安全性:一项随机、开放标签、标准治疗对照、2 期多中心研究(ONE-BRIDGE)。
Stem Cell Res Ther. 2023 Aug 22;14(1):217. doi: 10.1186/s13287-023-03451-z.

本文引用的文献

1
ISTH interim guidance on recognition and management of coagulopathy in COVID-19.国际血栓与止血学会(ISTH)关于新冠病毒病(COVID-19)凝血病识别与管理的临时指南。
J Thromb Haemost. 2020 May;18(5):1023-1026. doi: 10.1111/jth.14810. Epub 2020 Apr 27.
2
Personalised mechanical ventilation tailored to lung morphology versus low positive end-expiratory pressure for patients with acute respiratory distress syndrome in France (the LIVE study): a multicentre, single-blind, randomised controlled trial.法国急性呼吸窘迫综合征患者肺形态个体化机械通气与低呼气末正压通气的比较(LIVE 研究):一项多中心、单盲、随机对照试验。
Lancet Respir Med. 2019 Oct;7(10):870-880. doi: 10.1016/S2213-2600(19)30138-9. Epub 2019 Aug 6.
3
A Scoring System with High-Resolution Computed Tomography to Predict Drug-Associated Acute Respiratory Distress Syndrome: Development and Internal Validation.
基于高分辨率计算机断层扫描的药物相关性急性呼吸窘迫综合征预测评分系统:开发与内部验证。
Sci Rep. 2019 Jun 13;9(1):8601. doi: 10.1038/s41598-019-45063-9.
4
Acute Respiratory Distress Syndrome Phenotypes.急性呼吸窘迫综合征表型。
Semin Respir Crit Care Med. 2019 Feb;40(1):19-30. doi: 10.1055/s-0039-1684049. Epub 2019 May 6.
5
Clinical differences between pulmonary and extrapulmonary acute respiratory distress syndrome: a retrospective cohort study of prospectively collected data in Japan.肺内型与肺外型急性呼吸窘迫综合征的临床差异:一项对日本前瞻性收集数据的回顾性队列研究
J Thorac Dis. 2018 Oct;10(10):5796-5803. doi: 10.21037/jtd.2018.09.73.
6
Acute respiratory distress syndrome in mechanically ventilated patients with community-acquired pneumonia.机械通气社区获得性肺炎患者的急性呼吸窘迫综合征。
Eur Respir J. 2018 Mar 29;51(3). doi: 10.1183/13993003.02215-2017. Print 2018 Mar.
7
Adjunctive therapy with azithromycin for moderate and severe acute respiratory distress syndrome: a retrospective, propensity score-matching analysis of prospectively collected data at a single center.阿奇霉素辅助治疗中重度急性呼吸窘迫综合征:单中心前瞻性采集数据的回顾性倾向评分匹配分析。
Int J Antimicrob Agents. 2018 Jun;51(6):918-924. doi: 10.1016/j.ijantimicag.2018.02.009. Epub 2018 Feb 28.
8
Clinical characteristics and prognosis of drug-associated acute respiratory distress syndrome compared with non-drug-associated acute respiratory distress syndrome: a single-centre retrospective study in Japan.与非药物相关性急性呼吸窘迫综合征相比,药物相关性急性呼吸窘迫综合征的临床特征和预后:日本单中心回顾性研究。
BMJ Open. 2017 Nov 8;7(11):e015330. doi: 10.1136/bmjopen-2016-015330.
9
Predictors of diffuse alveolar damage in patients with acute respiratory distress syndrome: a retrospective analysis of clinical autopsies.急性呼吸窘迫综合征患者弥漫性肺泡损伤的预测因素:临床尸检回顾性分析。
Crit Care. 2017 Oct 20;21(1):254. doi: 10.1186/s13054-017-1852-5.
10
The negative effect of initial high-dose methylprednisolone and tapering regimen for acute respiratory distress syndrome: a retrospective propensity matched cohort study.初始大剂量甲泼尼龙和递减方案治疗急性呼吸窘迫综合征的负面影响:一项回顾性倾向匹配队列研究。
Crit Care. 2017 Jun 8;21(1):135. doi: 10.1186/s13054-017-1723-0.